Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Same-day collection in Bangkok
Instead, the compounding pharmacy assigns a Beyond-Use Date (BUD) based on stability testing of their specific formulation
Clinical research involving approximately 900 participants across six human trials specifically measured serum IGF-1 concentrations and found no changes with AOD-9604 treatment at doses up to 1 mg per day and beyond
Independent groups have observed consistent patterns across the published research record, providing cross-laboratory replication for the core mechanism findings documented in the foundational papers cited above
Similar services Ready for a transformative self-care experience?
Key Takeaways Yes retatrutide causes some muscle (lean mass) loss, but it is not selectively "eating" your muscle
